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Double or nothing: old chest X-ray as a clue to lung mass
ABSTRACT
Mucoepidermoid	carcinoma	is	a young	person’s	lung	cancer	with	no	apparent	causal	connection	to	smoking.	It	exhibits	slow	
growth,	which	can	make	it	challenging	to	detect	changes	in	size	on	serial	chest	imaging.	Another	way	of	describing	its	growth	
pattern	is	that	mucoepidermoid	carcinoma	has	an	unusually	long	volume	doubling	time.	We	describe	a case	of	an	incidental	lung	
nodule	diagnosed	as	mucoepidermoid	carcinoma	in	which	a prior	chest	radiograph	provided	a clue	to	the	indolent	nature	of	the	
abnormality	and	therefore	argued	against	typical	lung	cancer.	In	the	same	context,	we	underscore	the	value	of	volumetric	analy-
sis	in	improving	the	accuracy	of	nodule	growth	determinations,	which	further	strengthens	the	argument	that	the	importance	of	
locating	prior	imaging	has	not	diminished	in	contemporary	pulmonary	practice.	
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Introduction
The incidental pulmonary nodule is a com-
mon reason for pulmonology consultation in the 
current era of abundant medical imaging. While 
in an active or former smoker conventional 
smoking-related lung cancer is the dominant 
clinical concern, diagnostic considerations are 
more diverse in the never-smoker. In the eva-
luation of such patients, especially as imaging 
has become increasingly sophisticated, the 
importance of comparison films — something 
basic and cost-free — is nowadays easily over-
looked. We present a case of mucoepidermoid 
carcinoma of the lung in a young never-smoker, 
which illustrates that the value of prior images 
has not diminished even in today’s pulmonary 
practice. Besides discussing this rare indolent 
lung malignancy, we also address the concept 
of volumetric analysis — a modern technique 
that has made comparison imaging all the more 
relevant. 
 
Case report
A 49-year-old man presented to the emergency 
department (ED) of our trauma center after a motor 
vehicle collision in which he sustained a minor leg 
injury. On further questioning, he reported intermit-
tent nonproductive cough and night sweats over the 
past 3 months as well as unintentional weight loss 
of approximately 7 kg during the same period. His 
medical history included hypertension and diabetes 
mellitus. He had no personal history of lung disease 
or malignancy, although approximately 11 months 
earlier he had been diagnosed with pneumonia at 
another hospital and treated with outpatient anti-
biotics. No post-treatment follow-up took place. He 
had never smoked but had experienced significant 
second-hand smoke exposure in his youth.
Upon examination in the ED, he was hemo-
dynamically stable and afebrile. Cardiopulmonary 
auscultation was unremarkable. There were no 
palpable lymph nodes or masses. Routine labora-
tory evaluation was notable for normocytic anemia 
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Figure 1. A.	Frontal	chest	radiograph	performed	in	the	emergency	department	of	our	institution	showed	an	ovoid,	mass-like	density	in	the	retrocar-
diac	region	of	the	left	hemithorax	(arrowheads);	B.	Computed	tomography	of	the	chest	(coronal	reconstruction)	performed	without	administration	of	
intravenous	contrast	confirmed	the	presence	of	a lung	mass	in	the	posterior	basal	segment	of	the	left	lower	lobe	(star)	with	associated	obstruction	
of	the	segmental	bronchus	(blue	arrow);	C.	Comparison	frontal	chest	radiograph	performed	at	an	outside	institution	approximately	11	months	prior	
illustrated	minimal	interval	growth	of	the	lesion	(arrowheads)
Figure 2.	Microscopic	section	of	the	lung	tumor	showing	mucinous	
cells	(black	arrows),	intermediate	cells	(black	arrowheads),	and	a rare	
squamoid	cell	(white	arrow)	(Hematoxylin	&	eosin,	original	magnifica-
tion	×	200). 	Cellular	atypia	and	mitotic	figures	are	not	observed	(Ki67	
index	=	2%).  	These	findings	are	consistent	with	 low-grade	muco-
epidermoid	carcinoma	of	the	lung. Immunohistochemical	stains	were	
performed	to	exclude	competing	histologies	and	were	confirmatory
(hemoglobin 10.9 g/dL, normal range 14.0–18.0 
g/dL). Blood interferon-gamma release assay te-
sting was negative. Plain frontal chest radiograph 
(CXR) performed as part of the trauma protocol 
revealed an approximately 4 cm ovoid density 
in the retrocardiac region of the left hemithorax 
(Figure 1A). Subsequent computed tomography 
(CT) of the chest performed without intravenous 
contrast administration confirmed the presence 
of a lobular mass in the posterior basal segment 
of the left lower lobe (LLL) measuring approxima-
tely 3.8 cm in the greatest dimension (Figure 1B). 
Prior CXR taken 11 months earlier for the reported 
pneumonia demonstrated the same lesion (Figure 
1C) with interval change in diameter of only 8 mm.
On bronchoscopy, an endobronchial mass 
occupying the posterior basal segment bronchus of 
the LLL (LB10) was noted. Biopsy revealed clusters 
of mucinous cells interspersed among intermediate 
and squamoid cells with conspicuous absence of 
cellular atypia and mitotic activity consistent with 
low-grade mucoepidermoid carcinoma (Figure 2).
Upon establishing the diagnosis of low-gra-
de MEC, the patient was discharged from our 
hospital with instructions for evaluation by the 
thoracic oncology team of a cancer center located 
closer to his residence. He has not been seen in 
our institution since the time of discharge but 
reportedly has undergone resection of the MEC. 
Discussion
In a relatively young never-smoker with an 
incidentally detected lung mass, cell types other 
than the most common smoking-related histolo-
gies, which are small-cell carcinoma, squamous 
cell carcinoma, and lung adenocarcinoma, should 
merit serious consideration. There is a category 
of indolent lung malignancies not directly linked 
to smoking that deserves attention in such a sce-
nario (Table 1).
Support for the presence of one of these low-
grade tumors would be provided by demonstra-
ting that the so-called “volume doubling time” 
of the mass in question is very long. The volume 
doubling time (VDT) of a spherical tumor is a lo-
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Table 1. List of examples of slow-growing malignant primary lung tumor histologies
Histological cell type Remarks
Carcinoid Spherical,	vascularized,	usually	endobronchial
Mucoepidermoid	carcinoma Current	case
Adenoid	cystic	carcinoma Like	MEC	arises	from	submucosal	salivary	glands
Granular	cell	tumor Extremely	rare
BALT	lymphoma Indolent	lymphoproliferative	disorder
BALT	—	bronchus-associated	lymphoid	tissue;	MEC	—	mucoepidermoid	carcinoma
garithmic function that can be solved — assuming 
a constant growth rate — by measuring its diame-
ter on two different CXRs separated by a known 
period of time. According to the theory of expo-
nential tumor growth, the more rapidly dividing 
the neoplasm, the shorter will be its VDT in an 
exponential manner [1]. For example, using dia-
meter measurements on CXR, it has been deter-
mined that lung adenocarcinoma has a mean VDT 
of about 220 days, whereas the much more active 
small cell carcinoma has a VDT of about 86 days, 
with squamous cell carcinoma falling in between 
at about 115 days [2]. Limitations of the planar 
approach (CXR or CT) for extrapolating change in 
volume based on change in diameter include the 
assumption that the lesion is perfectly spherical, 
that it grows symmetrically, and that its diameter 
can be reliably determined — something that is 
subject to significant interobserver variability 
[3]. Additionally, because the volume of a sphere 
is related to the cube of its diameter, a simple 
comparison of diameters underestimates the 
degree of volume change. For example, a 10-fold 
increase in diameter from 1 mm to 1 cm (10 mm) 
corresponds to a 1000-fold (103) increase in volu-
me. In the modern era of CT scanning, it has be-
come possible to generate spatial reconstructions 
of lung nodules for volumetric analysis, which 
overcomes the deficiencies of two-dimensional 
methods and allows for direct volume calcula-
tions and comparisons (Figure 3). The expecta-
tion is that volumetry therefore results in more 
accurate determinations of VDT [4]. 
With the above principles in mind, it was 
felt that the most important initial diagnostic 
maneuver would be something fundamental and 
cost-free: obtaining the outside CXR performed 
11 months earlier for pneumonia, which indeed 
demonstrated the same lesion (Figure 1C) with 
interval change in diameter of only 8 mm, cor-
responding to a  doubling time of 359 days. 
Although compatible with some estimates for 
more indolent lung adenocarcinomas and even 
squamous cell carcinomas, such slow growth 
prompted consideration of unusual cell types 
such as MEC: the eventual diagnosis. 
MEC is a malignant salivary gland neopla-
sm that can rarely arise from the minor salivary 
glands of the bronchial submucosa. It accounts 
for < 1% of all lung cancers and is often diagno-
sed at an unusually young age: nearly a third of 
patients are under 40 [5]. There is no definitive 
etiological link to cigarette smoking, which likely 
accounts for its early presentation [6]. The usual 
gross appearance is that of a polypoid mass con-
fined to the airway lumen and frequently asso-
ciated with post-obstructive infection or mucus 
plugging [7]. MEC can be classified as low-grade 
or high-grade based on the degree of cellular 
atypia. With rare exceptions, low-grade tumors 
remain localized and therefore manifest 5-year 
survival rates exceeding 90% [5]. High-grade 
MEC, on the other hand, is an aggressive mali-
gnancy with a propensity for local invasion and 
distant spread; its survival figures are far inferior 
to those of low-grade MEC [5]. Surgical resection 
is considered the primary management strategy 
for this uncommon lung cancer and is feasible in 
the vast majority of cases.
This case illustrates how something as basic 
as a comparison with a prior CXR can help assess 
the growth pattern of a  lung mass and thereby 
categorize its aggressiveness. Strikingly indolent 
behavior increases clinical suspicion of unusual 
lung malignancies, among them MEC. In hind-
sight, it is apparent that what was diagnosed as 
pneumonia 11 months prior to our encounter 
with this patient was actually lung cancer in 
a young never-smoker, which highlights another 
important use of comparison chest imaging: do-
cumentation of pneumonia resolution following 
treatment. 
Conflict of interest
None declared.
Advances in Respiratory Medicine 2020, vol. 88, no. 1, pages 31–34
34 www.journals.viamedica.pl
Figure 3.	Example	of	volumetric	analysis	applied	to	a solitary	pulmonary	nodule	(white	arrow)	detected	on	an	initial	(A.)	and	12-month	follow-up	
(B.)	chest	computed	tomography.	The	corresponding	spatial	reconstructions	used	for	volumetric	calculations	are	shaded	in	green	in	panels	C.	and	D.	
The	interval	increase	in	nodule	diameter	of	13	mm	amounted	to	a 15%	change,	whereas	the	corresponding	increase	in	volume	of	288	mm3	amounted	
to	a 325%	change.		The	volume	doubling	time	(VDT)	extrapolated	from	the	change	in	diameter	was	580	days,	an	excessively	long	duration	for	usual	
lung	cancer	histologies.	The	VDT	derived	from	volume	measurements	was	214	days,	entirely	consistent	with	typical	lung	cancer	[4].	This	patient	
turned	out	to	have	adenocarcinoma	of	the	lung	(Image	reused,	with	permission,	from	Radiology	2017	©RSNA	[4])
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